These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9236562)

  • 1. A double-blind, placebo-controlled study of the effectiveness and safety of nizatidine in the prevention of postprandial heartburn.
    Spiegel JE; Thoden WR; Pappas K; Fratarcangelo P; Furey SA
    Arch Intern Med; 1997 Jul; 157(14):1594-9. PubMed ID: 9236562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nizatidine versus placebo in gastroesophageal reflux disease: a 12-week, multicenter, randomized, double-blind study.
    Cloud ML; Offen WW; Robinson M
    Am J Gastroenterol; 1991 Dec; 86(12):1735-42. PubMed ID: 1962618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On-demand treatment of acute heartburn with the antacid hydrotalcite compared with famotidine and placebo: randomized double-blind cross-over study.
    Holtmeier W; Holtmann G; Caspary WF; Weingärtner U
    J Clin Gastroenterol; 2007 Jul; 41(6):564-70. PubMed ID: 17577112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nizatidine versus placebo in gastro-oesophageal reflux disease: a 12-week, multicentre, randomised, double-blind study.
    Cloud ML; Offen WW; Robinson M
    Br J Clin Pract Suppl; 1994 Nov; 76():3-10. PubMed ID: 7794701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: an open-label, multiple-dose, randomized, multicenter clinical trial in 210 children.
    Orenstein SR; Gremse DA; Pantaleon CD; Kling DF; Rotenberg KS
    Clin Ther; 2005 Apr; 27(4):472-83. PubMed ID: 15922820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nizatidine versus placebo in gastro-oesophageal reflux disease: a 6-week, multicentre, randomised, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group.
    Cloud ML; Offen WW
    Br J Clin Pract Suppl; 1994 Nov; 76():11-9. PubMed ID: 7794700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying.
    Futagami S; Shimpuku M; Song JM; Kodaka Y; Yamawaki H; Nagoya H; Shindo T; Kawagoe T; Horie A; Gudis K; Iwakiri K; Sakamoto C
    Digestion; 2012; 86(2):114-21. PubMed ID: 22846371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of nizatidine, 75 mg, for the relief of episodic heartburn.
    Paul K; Redman CM; Chen M
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1571-7. PubMed ID: 11563996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of meal-induced heartburn and regurgitation with metoclopramide in patients with gastroesophageal reflux.
    Fuchs B; Bartolomeo RS
    Clin Ther; 1982; 5(2):179-85. PubMed ID: 6760968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of erosive reflux oesophagitis: a double-blind multicentre trial with nizatidine 300 mg b.i.d. versus placebo.
    Dobrilla G; Chilovi F; Tafner G; Vantini I; Bernardi A; Gentilini R; Fedrizzi F; Manfrini R; Steiner H; Mon M
    Ital J Gastroenterol; 1992; 24(6):338-41. PubMed ID: 1515660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Prilosec OTC (omeprazole magnesium 20.6 mg) to placebo for 14 days in the treatment of frequent heartburn.
    Allgood LD; Grender JM; Shaw MJ; Peura DA
    J Clin Pharm Ther; 2005 Apr; 30(2):105-12. PubMed ID: 15811162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies.
    Michael Hill C; Sindet-Pederson S; Seymour RA; Hawkesford JE; Coulthard P; Lamey PJ; Gerry Cowan C; Wickens M; Jeppsson L; Dean AD; Svensson O
    Clin Ther; 2006 Sep; 28(9):1279-95. PubMed ID: 17062301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lansoprazole 15 mg once daily for 14 days is effective for treatment of frequent heartburn: results of 2 randomized, placebo-controlled, double-blind studies.
    Kushner PR; Snoddy AM; Gilderman L; Peura DA
    Postgrad Med; 2009 Jul; 121(4):67-75. PubMed ID: 19641272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
    Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
    Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
    Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
    Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers.
    Houghton LA; Atkinson W; Whorwell PJ; Morris J; Murdoch RD; Cooper SM; Webber DM; Walls CM
    Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study.
    Singla N; Pong A; Newman K;
    Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
    Howden CW; Henning JM; Huang B; Lukasik N; Freston JW
    Am J Gastroenterol; 2001 Jun; 96(6):1704-10. PubMed ID: 11419818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.